# Dermatological: Topical Acne Products

## Length of Authorizations

365 Days

## All Authorizations

Must be prescribed in accordance with FDA approved labeling

## Non-Preferred Criteria

-   Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    -   For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
-   Must have had an inadequate clinical response of at least **30 days** (or **90 days** for retinoids) of at least **three preferred** drugs
    -   For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    -   For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

## Additional Tretinoin/Benzoyl Peroxide (Twyneo) Criteria

-   Must provide documentation for patient’s inability to use the individual drugs

## Additional Information

-   All retinoids – May be authorized with a diagnosis of skin cancer
-   Tazarotene (Tazorac) – May be authorized with a diagnosis or psoriasis

## Subsequent Authorization Criteria

-   Must provide documentation of patient’s clinical response to treatment and ongoing safety monitoring

**AR**- All topical retinoids: a PA is required for patients 24 years and older

## Topical Acne Products

Dermatological: Topical Acne Products

| PREFERRED                             | NON-PREFERRED                   |
|---------------------------------------|---------------------------------|
| Adapalene Gel 0.1% AR                 | Adapalene Cream, Sol 0.1% AR    |
| Azelex Cream                          | Adapalene Gel 0.3% AR           |
| Benzoyl Peroxide                      | Adapalene/Benzoyl Peroxide AR   |
| Clindamycin Gel                       | Aklief AR                       |
| Clindamycin Lot                       | Altreno AR                      |
| Clindamycin Sol                       | Amzeeq                          |
| Clindamycin/Benzoyl Peroxide          | Arazlo AR                       |
| Erythromycin                          | Azelaic Acid Gel                |
| Erythromycin/Benzoyl Peroxide         | Benzoyl Peroxide Foam           |
| Neuac                                 | Clindacin Kit                   |
| Sodium Sulfacetamide                  | Clindamycin Foam                |
| Sodium Sulfacetamide/Sulfur Cream     | Clindamycin Swabs               |
| Sodium Sulfacetamide/Sulfur Wash Susp | Clindamycin/Tretinoin AR        |
| Tretinoin AR                          | Dapsone Gel                     |
|                                       | Finacea Foam                    |
|                                       | Onexton Gel                     |
|                                       | Ovace Plus                      |
|                                       | Plixda AR                       |
|                                       | Sodium Sulfacetamide/Sulfur Gel |
|                                       | Sodium Sulfaetamide Pads        |
|                                       | Tazarotene Cream 0.1% AR        |
|                                       | Tazarotene Foam 0.1% AR         |
|                                       | Twyneo AR                       |
|                                       | Winlevi                         |

### Link to Criteria

[Dermatological: Topical Acne Products](https://pharmacy.medicaid.ohio.gov/sites/default/files/20220415_UPDL_Criteria_FINAL_.pdf#page=45)
